Natixis Advisors, L.P. Guardant Health, Inc. Transaction History

Natixis Advisors, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$99.96 - $135.93 $8.77 Million - $11.9 Million	-87,712 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$80.32 - $111.8 $122,487 - $170,495	1,525 Added 1.77%	87,712 $9.8 Million
Q2 2020 Aug 11, 2020	BUY	$60.49 - $97.5 $769,372 - $1.24 Million	12,719 Added 17.31%	86,187 $6.99 Million
Q1 2020 Apr 27, 2020	BUY	$59.04 - $88.81 $4.34 Million - $6.52 Million	73,468 New	73,468 $5.11 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.64B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.